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The G-protein-coupled receptor (GPCR) superfamily represents one of the largest classes of molecules
involved in signal transduction across the plasma membrane. Fluorescence-based approaches have
provided valuable insights into GPCR functions such as receptor–receptor and receptor–ligand inter-
actions, real-time assessment of signal transduction, receptor dynamics on the plasma membrane, and
intracellular trafficking of receptors. This has largely been possible with the use of fluorescent probes
such as the green fluorescent protein (GFP) from the jellyfish Aequoria victoria and its variants.
We discuss the potential of fluorescence-based approaches in providing novel information on the
membrane organization and dynamics of the G-protein-coupled serotonin1A receptor tagged to the
enhanced yellow fluorescent protein (EYFP).
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INTRODUCTION
The G-protein-coupled receptor (GPCR) superfam-
ily represents the largest class of molecules involved in
signal transduction across the plasma membrane [1]. This
class of membrane proteins includes about 1000–2000
members and represents ∼1% of the human genome
[2]. G-protein-coupled receptors respond to a variety of
ligands as diverse as biogenic amines, peptides, glyco-
proteins, lipids, nucleotides, and even photons, thereby
mediating multiple physiological processes such as neu-
rotransmission, cellular metabolism, secretion, cellular
differentiation, growth, and inflammatory and immune re-
sponses. As a consequence, GPCRs have emerged as ma-
jor targets for the development of novel drug candidates
in all clinical areas [3]. Disruption of GPCR signaling is
linked to disease conditions such as retinal degeneration
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and nephrogenic diabetes insipidus [4,5]. It is estimated
that up to 50% of clinically prescribed drugs act as ei-
ther agonists or antagonists at GPCRs with several lig-
ands of GPCRs among the top 100 globally selling drugs,
which points out their immense therapeutic potential
[5–7].
The common structural features of G-protein-
coupled receptors include seven transmembrane domains
with an extracellular N-terminus and a cytoplasmic C-
terminus. They are broadly categorized into three subfam-
ilies based on certain key sequences [8,9]. Rhodopsin-type
receptors (type A) are by far the largest and most ex-
tensively investigated group. Receptors belonging to this
group are activated by a large variety of stimuli includ-
ing odorants, photons, and small biogenic amines such as
serotonin, to large peptide hormones. The type B receptors
(calcitonin type) have a relatively large N-terminal extra-
cellular domain with six conserved cysteine residues. This
group includes receptors for peptides such as secretin and
glucagon. Metabotropic neurotransmitter receptors con-
stitute type C receptors, which have an exceptionally long
N-terminus and include the metabotropic glutamate and
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GABAB receptors. G-protein-coupled receptors transmit
signals across the plasma membrane via their interactions
with heterotrimeric G-proteins present on the cytoplas-
mic side of the cell membrane [10,11]. The G-protein
heterotrimer, composed of α, β, and γ subunits, is main-
tained in an inactive state by mutual association in a com-
plex, with the α subunit bound to a GDP moiety. Bind-
ing of specific ligands activates GPCRs by inducing or
stabilizing a conformational state of the receptor, which
can in turn activate heterotrimeric G-proteins. This re-
sults in exchange of GDP for GTP on the α subunit and
dissociation/reorganization of the complex, which facili-
tates transduction of signals to effector molecules such as
adenylate cyclase, phospholipases, and ion channels [10].
The multiple components of GPCR signal transduction
such as different types of receptors and G-protein subunits
provide cells with the much-needed versatility with which
to customize their responses to a diverse array of ligands,
which include hormones, neurotransmitters, and pharma-
cological agonists. Importantly, the spatiotemporal orga-
nization and dynamic confinement of receptors and effec-
tor molecules in the plasma membrane microdomains has
given rise to new challenges and complexities in receptor
signaling [12,13].
New technologies to analyze GPCR function in an
intact cellular environment are predicted to have a major
impact on GPCR research [3]. Such technologies currently
involve fluorescence-based approaches to gain insight into
GPCR functions such as receptor–receptor and receptor–
ligand interactions, real-time assessment of signal trans-
duction, receptor dynamics in the plasma membrane, and
intracellular trafficking of receptors. Fluorescence-based
approaches in general are considered superior over other
existing molecular detection technologies due to their en-
hanced sensitivity, minimal perturbation, multiplicity of
measurable parameters, and suitable time scales that al-
low the analysis of several biologically relevant molecu-
lar processes [14,15]. In this article, we provide a brief
overview on fluorescence-based approaches using aut-
ofluorescent proteins such as green fluorescent protein
to monitor membrane organization and dynamics of the
serotonin1A receptor, an important member of the GPCR
superfamily. The following sections are by no means an
exhaustive review on the development and applications of
fluorescent probes and proteins to monitor protein func-
tion in cells, for which several excellent articles are avail-
able [16–19]. This review aims to highlight the potential
of fluorescence imaging and fluorescence recovery after
photobleaching (FRAP) to yield novel information on the
membrane organization and dynamics of GPCRs using
the serotonin1A receptor as a representative member of
this class of proteins.
GREEN FLUORESCENT PROTEINS AS
SUITABLE FLUORESCENT PROBES
Green fluorescent protein (GFP) from the jellyfish
Aequoria victoria and its variants have become popular
reporter molecules for monitoring protein expression, lo-
calization, and dynamics of various membrane and cyto-
plasmic proteins [16]. Importantly, tagging GPCRs with
GFP has allowed direct visualization of signaling and
real-time trafficking in living cells [17,18]. They repre-
sent a convenient alternative to other fluorescent probes
for visualizing proteins due to the advantage of tagging
such proteins at the genetic level. This allows investiga-
tors to visualize proteins for a longer duration of time
in an intact cellular environment than is possible with
the use of other extrinsic fluorescent probes. The GFP in
Aequoria is a protein of 238 amino acids with a molec-
ular mass of ∼27 kDa, whose natural function is to con-
vert the blue chemiluminescence of the Ca2+-sensitive
photoprotein aqueorin into green light [20]. The forma-
tion of the chromophore in GFP involves an intrinsic
autocatalytic process that does not require additional en-
zymes or cofactors. This results in reconstitution of its
fluorescence in virtually all organisms. The chromophore
is p-hydroxybenzylideneimidazolidinone that is formed
posttranslationally after the protein adopts a native-like
11-stranded β-barrel structure [21] by a complex set of
reactions that primarily involve three residues in the pro-
tein, SYG (single-letter amino acid codes) at positions
65–67.
The GFP in Aequoria has the most complex spectra
of all GFPs. The protein has a predominant absorption
maximum at 395 nm at low pH and at 475 nm at high pH
[22,23]. Based on pH titration experiments that lead to
interconversion of the two species, the simplest interpre-
tation is that these species represent molecules in which
the phenol group in the tyrosine residue at position 66 has
different ionization states. The 395 nm peak corresponds
to molecules containing a neutral phenol group while the
475 nm peak corresponds to molecules with an anionic
phenolate group [24]. Although GFP is excited at two dif-
ferent wavelengths, only one emission peak is observed
under normal conditions. This is attributed to excited state
proton transfer reactions causing GFP molecules to adopt
a conformation that emits fluorescence with a peak cen-
tered at 507 nm [25]. The presence of such ground state
heterogeneity in natural GFPs, with a predominant species
excitable at 395 nm and a minor one excitable at 475 nm,
has few disadvantages in regular cell biological appli-
cations. The most apparent among them being the re-
quirement of UV light for efficient excitation of GFP that
can damage biological samples upon prolonged exposure.
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In addition, use of such low wavelengths can contribute
to scattering effects and autofluorescence. Excitation of
GFP with 475 nm wavelength could alleviate this prob-
lem. However, this results in excitation of a relatively
small (∼15%) fraction of molecules [16].
Site-directed mutagenesis has generated GFP vari-
ants that display relatively simple absorption spectra and
red-shifted spectral characteristics. The enhanced green
fluorescent protein (EGFP) [26], also referred to as GFP-
mut1 [27], is one such example, which bears two muta-
tions, F64L and S65T. The S65T mutation suppresses the
395 nm peak arising due to the neutral phenol group in the
tyrosine at position 66, and the 475 nm peak contributed
by the anionic phenolate group is enhanced 5–6 fold in
amplitude. In addition, the absorption maximum is shifted
to 489 nm with a maximum in fluorescence emission cen-
tered at 509 nm. Under normal cellular conditions, the
F64L mutation effectively leads to enhancement in net
fluorescence by allowing chromophore formation to oc-
cur at physiological temperatures [16,28]. The combined
result of these mutations is a GFP variant with a 5–6-
fold enhancement in fluorescence emission, excitable in
the visible wavelength range and with improved thermal
stability [28] relative to the wild-type GFP.
The enhanced yellow fluorescent protein (EYFP),
which displays enhanced brightness and a more red-
shifted fluorescence emission, represents another popu-
lar and well-characterized variant of GFP. This variant
was generated by site-directed mutation of GFP through
a rational-design approach [21]. The threonine residue
at position 203 in the GFP S65T mutant was replaced
with a tyrosine based on the proposal that placing an aro-
matic ring next to the phenolate ion of the chromophore
would result in π -stacking interactions between the chro-
mophore and the highly polarizable phenol group of the ty-
rosine residue. These interactions would reduce the energy
required for exciting the chromophore resulting in a GFP
variant with more red-shifted spectral properties than GFP
S65T [16,21,29]. Along with a few other mutations such
as V68L and S72A, this resulted in a yellow–green variant
of GFP with an excitation and emission maxima at 514
and 527 nm, respectively. This variant of GFP, referred to
as EYFP (previously known as GFP 10C, see [21]), has a
high molar extinction coefficient (ε) of 84,000 M−1 cm−1
and a quantum yield of 0.61, thus making it the brightest
among the popular GFP variants [30]. The absorption in
the visible range with enhanced brightness and other pho-
tophysical properties of EYFP have resulted in its use as
a probe to monitor protein expression, localization, and
dynamics in cells. EYFP–protein fusions have been used
to monitor protein expression and distribution, in addition
to monitoring near-neighbor interactions using fluores-
cence resonance energy transfer (FRET) with other vari-
ants of GFP such as the enhanced cyan fluorescent protein
(ECFP), in a wide variety of cell types [16]. The fluores-
cence properties of EYFP are highly sensitive to pH of
the environment resulting in its use as a noninvasive pH
indicator for intracellular organelles and cytoplasm [31].
The fluorescence intensity of EYFP reduces with a drop
in pH (apparent pKa = 6.5–7.1) [30,31] and is attributed
to a reduction in the population of molecules that absorb
and emit at 514 and 527 nm, respectively, with a concomi-
tant increase in a nonfluorescent population that absorbs
at 390 nm.
VISUALIZING G-PROTEIN-COUPLED
RECEPTORS USING GFP FLUORESCENCE
Visualization of GPCRs using fluorescence-based
approaches has tremendously improved our understand-
ing of their dynamic behavior in a cellular milieu. In-
formation regarding cellular distribution and traffick-
ing of GPCRs upon activation have predominantly been
obtained using fluorescence-based approaches [32]. G-
protein-coupled receptors have been visualized using flu-
orescent ligands, fluorescently labeled antibodies against
epitope-tagged GPCRs, and using GFPs [17,18,32]. The
use of fluorescent reporter proteins such as GFP has ad-
vantages over fluorescently labeled ligands and antibod-
ies to visualize receptors for the following reasons: (i)
the stoichiometry of the receptor and fluorescent pro-
tein is well defined as the latter is covalently attached
to the receptor at the genetic level, (ii) complications en-
countered while using fluorescent ligands such as ligand
dissociation, or while using fluorescent antibodies such
as nonspecific binding are avoided, (iii) this approach
allows analysis of the unliganded states of the receptor
(not possible with fluorescent ligands), (iv) the possibility
of perturbation induced by bulky fluorescent groups to
small endogenous ligands such as biogenic amines limits
their applicability, and (v) cellular biosynthesis ensures
the presence of receptors attached to fluorescent proteins
in cells and eliminates the necessity of labeling receptors
with fluorescent ligands and/or antibodies before each ex-
periment. Although GFPs were initially used for rather
low-end applications such as transfection markers, their
true potential as fluorescent reporters was soon realized
by their fusion with various proteins to monitor the sub-
cellular localization and trafficking of proteins [17]. The
original use of GFP as a fluorescent reporter for proteins
was to monitor gene expression [33]. One of the first ap-
plications of the GFP-fusion technology to GPCRs was
with the β2-adrenergic receptor to monitor their cellular
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distribution, ligand-dependent trafficking, and dynamics
on the plasma membrane [34]. The increasing use of
GPCR–GFP fusions to monitor receptor dynamics, traf-
ficking, and oligomerization has established the appli-
cability of this technology since then [17,18]. The fol-
lowing sections will review specific application of the
GPCR–GFP fusion technology to monitor novel aspects in
GPCR research such as their distribution in the membrane
and G-protein-dependent cell surface dynamics using the
serotonin1A receptor as an important representative of the
GPCR family of proteins.
THE SEROTONIN1A RECEPTOR: AN
IMPORTANT G-PROTEIN-COUPLED
RECEPTOR
The serotonin1A receptor belongs to the type A class
of GPCRs [9] and is one of the first GPCRs for which the
gene was cloned [35,36]. The gene is intronless and ex-
hibits ∼50% amino acid homology with the β2-adrenergic
receptor in the transmembrane domains [35]. The corre-
sponding mRNA is expressed mainly in the brain, spleen,
neonatal kidney, and gut [35,36]. The human gene for the
receptor encodes a protein of 422 amino acids with a core
molecular mass of ∼46 kDa. The serotonin1A receptor is
not yet purified and structural details at atomic resolu-
tion are not known [37]. However, hydropathy plots of
the amino acid sequences predict the presence of seven
putative transmembrane domains, each of ∼25 residues
in length, which are thought to represent membrane-
spanning α-helices (reviewed in [38,39]). Based on the
three consensus N-linked glycosylation sites in the amino
terminus, and its homology to the β2-adrenergic receptor,
the serotonin1A receptor is predicted to have a topology
where the amino terminus is oriented facing the extra-
cellular space. The hydrophilic sequences connecting the
transmembrane helices would form three intracellular and
extracellular loops in the protein with respect to the plasma
membrane. Receptors that bind to biogenic amines (such
as the serotonin1A receptor) are known to possess ligand
binding sites within the transmembrane regions [40]. Lig-
ands that act as agonists, bind to this pocket and induce
a conformational change in the transmembrane helices.
This change acts as a switch to activate G-proteins bound
to the second and third intracellular loops of the recep-
tor. Other structural features of the serotonin1A receptor
include a fourth cytoplasmic loop that is palmitoylated
posttranslationally at the two conserved cysteine residues
at the carboxy terminus of the receptor.
Serotonergic signaling is initiated by binding of the
intrinsically fluorescent [41] neurotransmitter serotonin
to distinct cell surface receptors. These receptors have
been classified into ∼14 subtypes on the basis of their
pharmacological responses to specific ligands, sequence
similarities at the gene and amino acid levels, gene orga-
nization, and second messenger coupling pathways [42].
Such signaling pathways play key roles in the gener-
ation and modulation of various cognitive and behav-
ioral functions such as sleep, mood, pain, addiction,
locomotion, sexual activity, depression, anxiety, alco-
hol abuse, aggression, and learning [39,43,44]. Disrup-
tions in serotonergic systems have been implicated in the
etiology of mental disorders such as schizophrenia, mi-
graine, depression, suicidal behavior, infantile autism, eat-
ing disorders, and obsessive-compulsive disorder [45,46].
In addition, serotonin receptors play a crucial role in
brain development processes such as neurogenesis and
axonal branching [47,48]. The serotonin1A receptor is
the most extensively studied of the serotonin recep-
tors for a number of reasons that include the availabil-
ity of a selective ligand 8-OH-DPAT (8-hydroxy-2-(di-
N-propylamino)tetralin) allowing extensive biochemical,
physiological, and pharmacological characterization of
the receptor, and its importance in neuronal physiology
[39]. As a result, the serotonin1A receptor represents an
important target in the development of therapeutic agents
for neuropsychiatric disorders such as anxiety and de-
pression. Importantly, the serotonin1A receptor knockout
mice exhibit enhanced anxiety-related behavior [49–51],
and represent an excellent model system to understand
such behavior in higher animals [52]. These reports point
toward the significance of serotonin1A receptors in human
health and disease.
While considerable information is available regard-
ing the pharmacology and neurobiology of the serotonin1A
receptors, molecular details regarding their organization
and dynamics in the membrane remain largely unex-
plored [37,39]. To address this issue, we have visu-
alized serotonin1A receptors stably expressed in mam-
malian cells by its fusion to EYFP [53]. A schematic
diagram indicating the site of the EYFP tag on the
serotonin1A receptor, and its typical fluorescence distri-
bution when stably expressed in Chinese hamster ovary
(CHO) cells are shown in Fig. 1. This fusion protein
was found to be essentially similar to the native re-
ceptor in pharmacological assays and therefore can be
used to reliably explore aspects of receptor biology
such as cellular distribution and dynamics on account
of its intrinsic fluorescent properties [53]. The follow-
ing sections describe the use of serotonin1A receptors
fused to EYFP in fluorescence-based approaches to an-
alyze their organization and dynamics in the plasma
membrane.
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Fig. 1. Visualization of the serotonin1A receptor in cells using EYFP fluorescence. (A) A schematic
diagram indicating the overall topology of the serotonin1A receptor with the site of the EYFP tag on
the receptor. (B) Typical fluorescence distribution of the serotonin1A receptor-EYFP fusion protein
stably expressed in Chinese hamster ovary (CHO) cells. The image represents a midplane section of
this group of cells acquired on a Zeiss LSM 510 Meta confocal microscope. The scale bar represents
10 µm.
MEMBRANE ORGANIZATION OF THE
SEROTONIN1A RECEPTOR MONITORED
USING GFP FLUORESCENCE
The role of organization of lipids and proteins in
membranes and its relevance in membrane function [54–
56] assumes significance in the context of the membrane
environment being an important modulator of membrane
protein function [57,58]. Increasing evidence favors the
concept of membranes being organized into domains
with defined lipid and protein compositions. These do-
mains, sometimes referred to as “rafts,” are believed to
serve as platforms for signaling by concentrating cer-
tain lipids (such as cholesterol and sphingolipids) and
proteins while excluding others [55,56,59]. Such an or-
ganization of membranes assumes importance due to its
potential role in a number of processes such as membrane
trafficking, sorting, signal transduction, and pathogen
entry [60–63].
Resistance to solubilization by mild nonionic de-
tergents such as Triton X-100 at low temperature repre-
sents an extensively used biochemical criterion to iden-
tify, isolate, and characterize certain types of membrane
domains [64–67]. Evidence from model membrane stud-
ies shows that enrichment with lipids such as sphin-
golipids (with high melting temperature) and choles-
terol serves as an important determinant for the phe-
nomenon of detergent resistance [68,69]. The tight acyl
chain packing in cholesterol-sphingolipid rich membrane
regions is thought to confer detergent resistance to mem-
brane regions enriched in these lipids and to the pro-
teins which reside in them. In spite of concerns over the
use of membrane-perturbing agents such as Triton X-100
to understand membrane organization [70,71], detergent
insolubility continues to be a principal tool to study mem-
brane domains due to its wide applicability [72]. Infor-
mation obtained from this extensively used biochemical
approach can often form the basis for a more detailed
analysis of membrane domains utilizing other specialized
techniques.
Detection of proteins in detergent-resistant mem-
branes (DRMs) is usually performed either by im-
munoblotting or ligand binding. However, these meth-
ods are not suitable in cases where ligand binding of
the protein in question is compromised in the presence
of the detergent [73,74] and/or is limited by availability
of antibodies with high specificity [75]. Membrane pro-
teins tagged with GFP provide an alternative, which can
overcome these difficulties. We have recently described
a GFP-fluorescence based approach to directly determine
detergent insolubility of the serotonin1A receptor [74].
This method is based on quantitating fluorescence of the
membrane protein before and after detergent treatment.
Utilizing this approach, ∼26% of fluorescence of the
serotonin1A receptor–EYFP fusion protein is shown to
be retained upon extraction with 0.05% (w/v) Triton X-
100 [74]. This represents the fraction of the serotonin1A
receptor, which is resistant to detergent treatment under
these conditions. A typical fluorescence distribution of
the serotonin1A receptor fused to EYFP upon detergent
extraction is shown in Fig. 2.
In order to validate this fluorescence microscopic ap-
proach toward determination of detergent insolubility of
membrane components, specific lipid (DiIC16 and FAST
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Fig. 2. Visualization of detergent insolubility of the serotonin1A receptor in CHO cells using
EYFP fluorescence. Cells expressing the serotonin1A receptor-EYFP fusion protein are shown
(A) before and (B) after treatment with 0.05% (w/v) cold Triton X-100 for 10 min. The images
represent combined midplane confocal sections of the same group of cells before and after
detergent extraction (from Ref. [74]). The scale bar represents 10 µm.
DiI) and protein (transferrin receptor) markers were uti-
lized, whose organization in membranes and the ability
to be extracted by cold nonionic detergents have been
well documented. The dialkylindocarbocyanine (DiI) se-
ries of lipid analogs have been shown to exhibit prefer-
ential phase partitioning into biological and model mem-
branes of varying degrees of order (fluidity) depending on
the relative headgroup to tail cross-sectional areas and the
chain length [76–78]. For example, DiIC16 with its two
16-carbon saturated alkyl chains preferentially partitions
into relatively rigid (highly ordered) domains, whereas
FAST DiI which has two 18-carbon chains with two cis
double bonds in each chain preferentially partitions into
fluid domains in membranes [78] since packing of this
probe would not be very efficient in an ordered phase. Or-
dered membrane domains and the proteins that partition
into them are known to be resistant to detergents [55]. Ac-
cordingly, when cells labeled with either of these probes
were extracted with Triton X-100, DiIC16 was found to
be insoluble in detergent to a greater extent than FAST DiI
[74]. These results show that this method is capable of
distinguishing ordered domains labeled by DiIC16 from
the fluid regions of the membrane characterized by FAST
DiI labeling. This fluorescence-based approach for deter-
mining detergent insolubility of membrane components
has been further tested by monitoring detergent insol-
ubility of a protein marker, the transmembrane protein
transferrin receptor. Several reports have earlier shown
this receptor to be soluble in Triton X-100 and therefore it
is often used as one of the controls for detergent insolubil-
ity experiments [79,80]. In agreement with these reports,
transferrin receptor is found to be largely soluble in Tri-
ton X-100 by the GFP-based fluorescence approach to
monitor detergent insolubility of the serotonin1A receptor
[74].
Taken together, results obtained using the lipid (DiI)
and protein (transferrin receptor) markers validated the
observation of detergent insolubility of the serotonin1A
receptor in particular, and the GFP fluorescence-based
approach in general. Importantly, this method of anal-
ysis of detergent insolubility could be potentially use-
ful in exploring membrane localization of other G-
protein-coupled receptors. In addition, this approach
is free from possible artifacts induced by antibod-
ies in immunoblotting experiments. Thus, this GFP
fluorescence-based approach represents a useful appli-
cation of GPCR–GFP fusion proteins to explore mem-
brane organization of G-protein-coupled receptors. This
approach has the potential to be used in large-scale screen-
ings of detergent insolubility of membrane proteins by
making fluorescent fusion proteins and testing for in-
solubility by an automated fluorescence imaging system
capable of handling multiple samples.
MEMBRANE DYNAMICS OF THE SEROTONIN1A
RECEPTOR MONITORED USING GFP
FLUORESCENCE
The major paradigm in the G-protein-coupled re-
ceptor signal transduction process is that activation of
GPCRs leads to the recruitment and activation of het-
erotrimeric GTP-binding proteins (G-proteins) [11]. The
activation process stimulates the GDP–GTP exchange on
the α-subunit of the G-protein leading to dissociation of
the heterotrimer from the GPCR. These initial events are
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fundamental to all types of GPCR signaling and occur at
the plasma membrane via protein–protein interactions.
Hence, the dynamics of the activated receptor on the
cell surface represents an important determinant in its
encounter with G-proteins and has a significant impact
on the overall efficiency of the signal transduction pro-
cess. This aspect forms the basis of the “mobile receptor”
hypothesis in which the lateral mobility of the receptor
on the cell surface is assumed to play an important role
in receptor–effector interactions at the plasma membrane
that determine efficiency of cellular signaling processes
[81]. This model has evolved over time due to novel find-
ings on G-protein-coupled signal transduction events. Re-
cent evidence indicates that receptors and G-proteins are
less dynamic than previously appreciated. A spatiotem-
porally organized system rather than a freely diffusible
system has been suggested to be responsible for rapid and
specific propagation of extracellular stimuli to intracellu-
lar signaling molecules [12,82]. It has been proposed that
GPCRs and their cognate G-proteins are not uniformly
present on the plasma membrane but are concentrated in
specific membrane microdomains [13]. This heterogenous
distribution of GPCRs and G-proteins into domains has
given rise to new challenges and complexities in receptor
signaling since it now has to be understood in the context
of the three-dimensional organization of various signaling
components.
In light of the proposed significance of a spatiotem-
porally restricted environment in modulating receptor and
G-protein interaction, we have utilized the intrinsic fluo-
rescence of the human serotonin1A receptor tagged to the
enhanced yellow fluorescent protein (EYFP) to analyze its
cell surface dynamics (diffusion characteristics) using the
technique of fluorescence recovery after photobleaching
(FRAP) [53]. Fluorescence recovery after photobleaching
involves generating a concentration gradient of fluores-
cent molecules by irreversibly photobleaching a fraction
of fluorophores in the observation region. The dissipa-
tion of this gradient with time owing to diffusion of flu-
orophores into the bleached region from the unbleached
regions in the membrane is an indicator of the mobility
of the fluorophores in the membrane [83,84]. Fluores-
cence recovery after photobleaching is one of the most
widely used approaches to quantitatively estimate diffu-
sion characteristics of molecules in solution and cellular
systems. However, obtaining consistent and reliable quan-
titative estimates of mobility of molecules using FRAP is
hindered by the lack of appropriate standards for calibrat-
ing the FRAP setup (microscope configuration and data
fitting algorithms) used in a given experiment. We have
validated our approach to analyze the cell surface dynam-
ics of the serotonin1A receptor by independent measure-
ment of the mobility of a standard solution of EGFP in
a viscous solution. Our experimentally determined dif-
fusion coefficient of EGFP under such conditions is in
excellent agreement with the value predicted for GFP in
a solution of comparable viscosity as calculated using
the Stokes–Einstein equation [53]. Fluorescence recovery
after photobleaching analysis carried out in a similar man-
ner on serotonin1A receptors fused to EYFP indicate that
the mobility of the receptor is dependent on its interaction
with G-proteins. Prior incubation with agents that activate
G-proteins through receptor-dependent and -independent
means increases receptor mobility on the plasma mem-
brane. A typical FRAP measurement performed on cells
expressing the serotonin1A receptor–EYFP fusion under
optimized imaging conditions is shown in Fig. 3. The fig-
ure also shows the effect of aluminum fluoride (AlF4−), a
receptor-independent activator of G-proteins in cells, on
the kinetics of fluorescence recovery after photobleach-
ing of the serotonin1A receptor–EYFP fusion. The G-
protein heterotrimer is a large protein complex with an
average molecular mass of ∼88 kDa [85], which would
be ∼1.2 times the mass of the receptor tagged to EYFP.
It is therefore possible that their association with the re-
ceptor would reduce its mobility. Receptor-dependent and
-independent activation of G-proteins stimulates the ex-
change of a GTP for the existing GDP molecule at the
Gα subunit of G-proteins, resulting in the dissociation of
G-protein heterotrimer complex from the receptor. The
proposal that the association of G-proteins to the receptor
reduces its mobility is further validated by the observation
that treatment of cells with pertussis toxin that reduces re-
ceptor and G-protein interaction also causes an increase
in receptor mobility [53]. Importantly, these results for the
first time provide convincing evidence that the cell surface
dynamics of a GPCR is dependent on its interaction with
G-proteins.
Diffusion behavior of several integral membrane pro-
teins indicates that the cytoskeleton underlying the plasma
membrane can act as a barrier to free diffusion of these
proteins. This is thought to occur due to the steric hin-
drance imposed by the cytoskeleton on the cytoplasmic
domains of these proteins. Treatment of cells with agents
that disrupt the cytoskeleton [86], truncation of the cy-
toplasmic domains of transmembrane proteins [87], or a
lack of interaction of membrane proteins with cytoplas-
mic effector molecules [88] tends to increase their mo-
bility on the cell surface. Likewise, the presence of the
bulky heterotrimeric G-protein complex associated with
the receptor (since G-proteins, when bound to membrane
receptors, could be considered as equivalent to cytoplas-
mic domains of membrane proteins) could further reduce
(over the differences arising due to molecular mass of
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Fig. 3. Fluorescence recovery after photobleaching (FRAP) of serotonin1A receptors fused to EYFP in CHO
cells. (A) Confocal fluorescence images corresponding to the base of the same cell are shown before and after
photobleaching for the indicated duration of time. The prebleach image is shown at time t < 0 and the bleach event
is shown at time t = 0. (B) Normalized fluorescence intensity in regions 1 (bleach region) and 2 (control region)
of the images in panel A are shown for the entire duration of the FRAP experiment. The constant fluorescence
intensity in region 2 indicates no significant photobleaching of the field due to repeated imaging. The prebleach
intensities are shown at time, t < 0. (C) Typical fluorescence recovery plots of the serotonin1A receptor–EYFP
fusion protein in cells in the absence (–◦–) or presence (–•–) of aluminum fluoride (AlF4−), a receptor-independent
activator of G-proteins. The curves are nonlinear regression fits to the model describing fluorescence recovery
under uniform disk illumination condition. The scale bar represents 5 µm. The plot in (C) is adapted from Ref.
[53].
G-proteins) receptor diffusion, which would be partially
relieved when the G-protein dissociates from the recep-
tor. Another possibility could be that the increase in re-
ceptor diffusion could reflect changes in the oligomeric
state of the receptor, as has been shown for the δ-opioid
receptor [89] and the cholecystokinin receptor [90], or
their partitioning into or out of domains proposed to ex-
ist on the cell surface [12,13]. There is growing evidence
on the compartmentalized localization of G-proteins in
detergent-insoluble, cholesterol-rich membrane domains
[91], which have been reported to diffuse as separate en-
tities on the membrane [92]. Importantly, we have earlier
observed that the cell surface dynamics of the serotonin1A
receptor is modulated by membrane cholesterol [93], an
essential constituent of such domains [55,68]. Whether
the differences in the diffusion properties of the receptor
while being associated with or without G-proteins result
from the movement of receptors into or out of such do-
mains enriched in cholesterol represents an interesting
possibility and is currently being addressed in our labo-
ratory. Our results on the G-protein-dependent cell sur-
face dynamics of the serotonin1A receptor provide novel
insight into signal transduction involving this receptor.
Due to similarity in the initial events of signal transduc-
tion involving GPCRs, it is possible that the increase in
receptor mobility upon G-protein activation could take
place in case of other GPCRs as well. Analysis of GPCR
mobility therefore could be a sensitive and powerful ap-
proach to assess receptor/G-protein interaction in intact
cells.
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CONCLUSIONS AND FUTURE PERSPECTIVES
The development of fluorescence-based approaches
to monitor protein expression, distribution, and dynam-
ics has tremendously contributed to the understanding of
protein functions in an intact cellular environment. Tech-
niques for visualizing proteins in cells have earlier relied
on the use of fluorescently labeled antibodies and ligands.
The GFP-fusion technology represents an important de-
velopment in fluorescence imaging of cellular proteins.
In combination with imaging technologies with improved
signal-to-noise ratio and with enhanced spatial and tempo-
ral resolution, the use of autofluorescent proteins to mon-
itor protein function in real time in cells appears poised
for further growth.
However, the use of GFPs as fluorescent reporters has
a few limitations. The early variants of GFPs have been
reported to display a tendency to self-associate into dimers
[16]. Such associations can induce significant artifacts in
fluorescence resonance energy transfer experiments due to
erroneous estimation of proximity of proteins tagged with
GFP. The generation of nonoligomerizing mutants of GFP
variants has provided an alternative to this problem [19].
The most notable limitation of the GFP family of proteins
as fluorescent markers is their molecular mass (∼27 kDa)
that is large enough to induce perturbations upon fusion
to relatively smaller proteins or proteins that function as
part of large organized assemblies. For instance, the ki-
netics of the agonist-dependent internalization of the β1-
and β2-adrenoceptors are slower for receptors tagged to
GFP [94]. In addition, single-channel properties of the
pentameric neuronal nicotinic acetylcholine receptor have
been reported to be altered by fusion of its subunits with
GFP [95].
Such limitations may be overcome with the use of
smaller fluorescent probes. A promising alternative to
GFP is the biarsenical-tetracysteine system, more specif-
ically the fluorescein arsenical hairpin binder (FlAsH)
[96–98]. FlAsH is fluorescent only when bound to a
small tetracysteine motif, CCPGCC that can be intro-
duced into proteins at the genetic level. The applicability
of this technology is still limited due to partial reactiv-
ity of the fluorescent probe to proteins containing the
tetracysteine motif in a cellular environment, in addition
to high background staining that reduces its sensitivity
compared to GFPs [19]. Nonetheless, a recent report de-
scribes the use of this fluorescent reporter to visualize a
GPCR, the adenosine A2A receptor, in intact cells [98].
Another constraint with GFP-like proteins is the compli-
cated photophysics of such molecules that leads to phe-
nomena such as reversible photobleaching. These charac-
teristics are exhibited by several variants of GFPs and can
induce significant artifacts in photobleaching experiments
to determine molecular mobility and in resonance energy
transfer experiments to determine proximity of molecules
[99]. Such artifacts can be minimized with the use of
fluorescent proteins such as EYFP that show minimal re-
versible photobleaching compared to other variants such
as ECFP [99]. Alternatively, techniques that provide in-
formation on molecular mobility but are not based on fluo-
rescence photobleaching, such as fluorescence correlation
spectroscopy (FCS) [100], can be employed to measure
diffusion rates of molecules. Importantly, discrete analysis
of subpopulations of molecules diffusing at different rates
can be conveniently carried out using fluorescence cor-
relation spectroscopy. The application of this technique
to detect the presence of multiple diffusing populations
of the serotonin1A receptor and the relative abundance of
these populations under conditions of receptor activation
represents a useful means to analyze receptor function.
Notwithstanding these shortcomings, the GFP-
fusion technology continues to be a powerful tool to mon-
itor expression, localization, and mobility of cellular pro-
teins in general, and GPCRs in particular, even after more
than a decade since it was first used. Ongoing efforts to
develop newer fluorescence-based probes, some of them
generated by mutating existing GFP variants for enhanced
brightness, more red-shifted spectral properties, reduced
sensitivity to pH and halides, and the ability to be activated
by light [19], combined with enhanced fluorescence de-
tection technologies, would certainly contribute to a more
refined understanding of the molecular aspects of cellular
functions in the future.
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